{
  "trial_id": "NCT00321555",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, Eastern Cooperative Oncology Group (ECOG) performance status, absolute neutrophil count (ANC), hemoglobin (Hgb) level, platelet (Plt) count, absolute lymphocyte count, presence of symptomatic splenomegaly, prior treatments received, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, albumin level, total bilirubin level, creatinine level, creatinine clearance, pregnancy status (for females), left ventricular ejection fraction, diffusing capacity of the lungs for carbon monoxide (DLCO), forced expiratory volume 1 (FEV1), presence of human immunodeficiency virus (HIV) or hepatitis C, presence of active second malignancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "pregnancy status (for females)"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "gender",
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "absolute neutrophil count (ANC)",
        "hemoglobin (Hgb) level",
        "platelet (Plt) count",
        "absolute lymphocyte count",
        "presence of symptomatic splenomegaly",
        "prior treatments received",
        "alanine aminotransferase (ALT) level",
        "aspartate aminotransferase (AST) level",
        "albumin level",
        "total bilirubin level",
        "creatinine level",
        "creatinine clearance",
        "left ventricular ejection fraction",
        "diffusing capacity of the lungs for carbon monoxide (DLCO)",
        "forced expiratory volume 1 (FEV1)",
        "presence of human immunodeficiency virus (HIV) or hepatitis C",
        "presence of active second malignancy"
      ]
    },
    "processed-gen-response": "Age, gender, race, Eastern Cooperative Oncology Group (ECOG) performance status, absolute neutrophil count (ANC), hemoglobin (Hgb) level, platelet (Plt) count, absolute lymphocyte count, presence of symptomatic splenomegaly, prior treatments received, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, albumin level, total bilirubin level, creatinine level, creatinine clearance, pregnancy status (for females), left ventricular ejection fraction, diffusing capacity of the lungs for carbon monoxide (DLCO), forced expiratory volume 1 (FEV1), presence of human immunodeficiency virus (HIV) or hepatitis C, presence of active second malignancy."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline CD25 expression, Absolute neutrophil count (ANC), Hemoglobin (Hgb) level, Platelet (Plt) count, Absolute lymphocyte count, Splenomegaly status, Previous treatments, ECOG performance status, Alanine aminotransferase (ALT) level, Aspartate aminotransferase (AST) level, Albumin level, Total bilirubin level, Creatinine level, Creatinine clearance, Serum neutralization of LMB-2 activity, Left ventricular ejection fraction, Diffusing capacity of the lungs for carbon monoxide (DLCO), Forced expiratory volume 1 (FEV1), ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Baseline CD25 expression",
        "Absolute neutrophil count (ANC)",
        "Hemoglobin (Hgb) level",
        "Platelet (Plt) count",
        "Absolute lymphocyte count",
        "Splenomegaly status",
        "Previous treatments",
        "ECOG performance status",
        "Alanine aminotransferase (ALT) level",
        "Aspartate aminotransferase (AST) level",
        "Albumin level",
        "Total bilirubin level",
        "Creatinine level",
        "Creatinine clearance",
        "Serum neutralization of LMB-2 activity",
        "Left ventricular ejection fraction",
        "Diffusing capacity of the lungs for carbon monoxide (DLCO)",
        "Forced expiratory volume 1 (FEV1)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline CD25 expression, Absolute neutrophil count (ANC), Hemoglobin (Hgb) level, Platelet (Plt) count, Absolute lymphocyte count, Splenomegaly status, Previous treatments, ECOG performance status, Alanine aminotransferase (ALT) level, Aspartate aminotransferase (AST) level, Albumin level, Total bilirubin level, Creatinine level, Creatinine clearance, Serum neutralization of LMB-2 activity, Left ventricular ejection fraction, Diffusing capacity of the lungs for carbon monoxide (DLCO), Forced expiratory volume 1 (FEV1)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Hemoglobin, Absolute Neutrophil Count, Platelet Count, Absolute Lymphocyte Count, Splenomegaly, Prior systemic therapies, CD25 expression,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Hemoglobin",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Absolute Lymphocyte Count",
        "Splenomegaly",
        "Prior systemic therapies",
        "CD25 expression"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Hemoglobin, Absolute Neutrophil Count, Platelet Count, Absolute Lymphocyte Count, Splenomegaly, Prior systemic therapies, CD25 expression"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, weight, height, ECOG performance status, absolute neutrophil count (ANC), hemoglobin (Hgb), platelet (Plt) count, absolute lymphocyte count, presence of symptomatic splenomegaly, prior systemic therapies, CD25 expression level, albumin level, ALT, AST, total bilirubin, creatinine, creatinine clearance, left ventricular ejection fraction, DLCO, FEV1.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "ECOG performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "absolute neutrophil count (ANC)",
        "hemoglobin (Hgb)",
        "platelet (Plt) count",
        "absolute lymphocyte count",
        "presence of symptomatic splenomegaly",
        "prior systemic therapies",
        "CD25 expression level",
        "albumin level",
        "ALT",
        "AST",
        "total bilirubin",
        "creatinine",
        "creatinine clearance",
        "left ventricular ejection fraction",
        "DLCO",
        "FEV1"
      ]
    },
    "processed-gen-response": "Age, sex, race, weight, height, ECOG performance status, absolute neutrophil count (ANC), hemoglobin (Hgb), platelet (Plt) count, absolute lymphocyte count, presence of symptomatic splenomegaly, prior systemic therapies, CD25 expression level, albumin level, ALT, AST, total bilirubin, creatinine, creatinine clearance, left ventricular ejection fraction, DLCO, FEV1."
  }
}